1 |
0.9% sodium chloride |
Chloride ion |
1件: D02056 D02056 💬 |
- |
- |
006 4件: 6 , 14, 51, 53 💬 |
2 |
0.9% sodium chloride (normal saline) |
Chloride ion |
1件: D02056 D02056 💬 |
- |
- |
006 1件: 6 💬 |
3 |
0.9% sodium chloride injection |
Chloride ion |
1件: D02056 D02056 💬 |
- |
- |
168 1件: 168 💬 |
4 |
0.9% w/v isotonic sodium chloride solution |
Chloride ion |
1件: D02056 D02056 💬 |
- |
- |
050 1件: 50 💬 |
5 |
0.9% w/v sodium chloride solution |
Chloride ion |
1件: D02056 D02056 💬 |
- |
- |
299 1件: 299 💬 |
6 |
0109-0012a 100 mg/ml |
- |
- |
- |
- |
046 1件: 46 💬 |
7 |
100 |
- |
- |
- |
- |
006 2件: 6 , 97 💬 |
8 |
100 mg |
- |
- |
- |
- |
097 1件: 97 💬 |
9 |
100 mg ap1189 |
- |
- |
- |
- |
222 1件: 222 💬 |
10 |
100 mg elx /50 mg tez /75 mg iva fdc |
- |
- |
- |
- |
299 1件: 299 💬 |
11 |
100 mg elx/50 mg tez /75 mg iva fdc |
- |
- |
- |
- |
299 1件: 299 💬 |
12 |
100 mg elx/50 mg tez/75 mg iva fixed dose combination |
- |
- |
- |
- |
299 1件: 299 💬 |
13 |
100 mg lx3305 qd |
- |
- |
- |
- |
046 1件: 46 💬 |
14 |
100 mg tez/150 mg iva fdc |
- |
- |
- |
- |
299 1件: 299 💬 |
15 |
100 mg vx-445/50 mg tez /75 mg iva fdc |
- |
- |
- |
- |
299 1件: 299 💬 |
16 |
100 mg/m2 dose |
- |
- |
- |
- |
299 1件: 299 💬 |
17 |
100 µg brimonidine tartrate implant |
Brimonidine |
2件: D02076 D02076, D07540 D07540 💬 |
ADRA2A 3件: ADRA2A, ADRA2B, ADRA2C 💬 |
Neuroactive ligand-receptor interaction 2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway |
090 1件: 90 💬 |
18 |
100-mg elx (vx-445) / 50-mg tez / 75-mg iva fdc |
- |
- |
- |
- |
299 1件: 299 💬 |
19 |
100-mg elx (vx-455) / 50-mg tez / 75-mg iva fdc |
- |
- |
- |
- |
299 1件: 299 💬 |
20 |
100-mg elx / 50-mg tez / 75 -mg iva fdc |
- |
- |
- |
- |
299 1件: 299 💬 |
21 |
100-mg vx-445 / 50-mg tez / 75-mg iva fdc |
- |
- |
- |
- |
299 1件: 299 💬 |
22 |
100-mg vx-445 /50-mg tez/75-mg |
- |
- |
- |
- |
299 1件: 299 💬 |
23 |
100-mg vx-445/50-mg tez/75-mg iva fdc |
- |
- |
- |
- |
299 1件: 299 💬 |
24 |
1000 iu d3 |
- |
- |
- |
- |
096 1件: 96 💬 |
25 |
10000iu vitamin d |
Vitamin D |
- |
- |
- |
013 1件: 13 💬 |
26 |
100mcg rhpth(1-84) |
Parathyroid hormone |
1件: D05364 D05364 💬 |
PTH1R 2件: PTH1R, PTH2R 💬 |
Endocrine and other factor-regulated calcium reabsorption 3件: Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action |
235 1件: 235 💬 |
27 |
100mg vx-445/50mg tez /75mg iva fdc |
- |
- |
- |
- |
299 1件: 299 💬 |
28 |
[cc-10004] |
- |
- |
- |
- |
097 1件: 97 💬 |
29 |
Abx464 100mg |
- |
- |
- |
- |
046 2件: 46, 97 💬 |
30 |
Acetyl-l-carnitine 1000mg 2x per day for 3 months |
Acetylcarnitine |
3件: D02030 D02030, D02176 D02176, D04713 D04713 💬 |
- |
- |
298 1件: 298 💬 |
31 |
Active drug (biib014) at 10, 30, 100, or 300 mg once daily. |
- |
- |
- |
- |
006 1件: 6 💬 |
32 |
Actrapid 100 iu/ml, solution for injection in a vial |
- |
- |
- |
- |
299 1件: 299 💬 |
33 |
Actrapid penfill 100ui/ml |
- |
- |
- |
- |
299 1件: 299 💬 |
34 |
Advate 1000 iu powder and solvent for solution for injection |
- |
- |
- |
- |
288 1件: 288 💬 |
35 |
Advate 1000iu powder and solvent for solution for injection |
- |
- |
- |
- |
288 1件: 288 💬 |
36 |
Allogeneic cardiosphere-derived cells (cap-1002) |
CAP-1002 |
- |
- |
- |
113 1件: 113 💬 |
37 |
Allopurinol sandoz 100 mg, tabletten |
Allopurinol |
1件: D00224 D00224 💬 |
XDH 1件: XDH 💬 |
Caffeine metabolism 5件: Caffeine metabolism, Drug metabolism - other enzymes, Metabolic pathways, Peroxisome, Purine metabolism |
096 1件: 96 💬 |
38 |
Alpha-1 hc 100 mg |
- |
- |
- |
- |
299 1件: 299 💬 |
39 |
Alphanate 1000 i.u. |
- |
- |
- |
- |
288 1件: 288 💬 |
40 |
Alphanate*inf 1f 1000ui+f 10ml |
- |
- |
- |
- |
288 1件: 288 💬 |
41 |
Amantadin-ratiopharm 100mg |
- |
- |
- |
- |
006 1件: 6 💬 |
42 |
American ginseng extract ht-1001 |
Ginseng |
1件: D06772 D06772 💬 |
- |
- |
013 1件: 13 💬 |
43 |
Androgel 10 grams of gel containing 100 mg of testosterone |
Testosterone |
6件: D00075 D00075, D00957 D00957, D00958 D00958, D00959 D00959, D06085 D06085, D06087 D06087 💬 |
AR 1件: AR 💬 |
Oocyte meiosis 3件: Oocyte meiosis, Pathways in cancer, Prostate cancer |
013 1件: 13 💬 |
44 |
Anifrolumab 1000 mg |
Anifrolumab |
1件: D11082 D11082 💬 |
IFNAR1 2件: IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
049 1件: 49 💬 |
45 |
Antimicrobial therapy: co-trimoxazole or doxycycline |
Doxycycline |
5件: D00307 D00307, D02129 D02129, D03903 D03903, D03904 D03904, D07876 D07876 💬 |
- |
- |
085 1件: 85 💬 |
46 |
Apremilast (cc-10004) |
Apremilast |
1件: D08860 D08860 💬 |
PDE4A 4件: PDE4A, PDE4B, PDE4C, PDE4D 💬 |
Metabolic pathways 5件: Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway |
056 1件: 56 💬 |
47 |
Aqx-1125 100 mg |
AQX-1125 |
- |
- |
- |
226 1件: 226 💬 |
48 |
Ataluren 1000 mg |
Ataluren |
1件: D09323 D09323 💬 |
- |
- |
113 1件: 113 💬 |
49 |
Ataluren 1000mg |
Ataluren |
1件: D09323 D09323 💬 |
- |
- |
246 1件: 246 💬 |
50 |
Azd3241 100mg |
- |
- |
- |
- |
017 1件: 17 💬 |
51 |
Azd3241 extended release tablets 100 mg |
- |
- |
- |
- |
006 1件: 6 💬 |
52 |
Bassado 10cps 100mg |
- |
- |
- |
- |
023 1件: 23 💬 |
53 |
Belimumab 100 mg sc |
Belimumab |
1件: D03068 D03068 💬 |
TNFSF13B 1件: TNFSF13B 💬 |
Cytokine-cytokine receptor interaction 4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis |
049 1件: 49 💬 |
54 |
Bi 1265162 100 µg |
- |
- |
- |
- |
299 1件: 299 💬 |
55 |
Bia 6-512 100 mg |
BIA |
- |
- |
- |
006 1件: 6 💬 |
56 |
Bia 6-512 100 mg dose |
BIA |
- |
- |
- |
006 1件: 6 💬 |
57 |
Biological : i10e (human normal immunoglobulin for intravenous administration 100mg/ml) |
Human immunoglobulin G |
- |
- |
- |
014 1件: 14 💬 |
58 |
Biological: kiovig® (human normal immunoglobulin for intravenous administration 100mg/ml) |
Human immunoglobulin G |
- |
- |
- |
014 1件: 14 💬 |
59 |
Botox 100 unites allergan (pr1) |
- |
- |
- |
- |
002 1件: 2 💬 |
60 |
Bt-11 (1000 mg) |
- |
- |
- |
- |
097 1件: 97 💬 |
61 |
Bt-11 1000mg |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
62 |
Caffeine 100 mg |
Caffeine |
2件: D00528 D00528, D01453 D01453 💬 |
ADORA1 11件: ADORA1, ADORA2A, PDE1B, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE5A 💬 |
Alcoholism 22件: Alcoholism, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Parkinson disease, Progesterone-mediated oocyte maturation, Purine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Taste transduction, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
096 2件: 96, 97 💬 |
63 |
Caffeine 100-200 mg bid |
Caffeine |
2件: D00528 D00528, D01453 D01453 💬 |
ADORA1 11件: ADORA1, ADORA2A, PDE1B, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE5A 💬 |
Alcoholism 22件: Alcoholism, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Parkinson disease, Progesterone-mediated oocyte maturation, Purine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Taste transduction, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
006 1件: 6 💬 |
64 |
Calvan® 100 mg |
- |
- |
- |
- |
008 1件: 8 💬 |
65 |
Cap-1002 |
CAP-1002 |
- |
- |
- |
113 1件: 113 💬 |
66 |
Capsules containing: carbidopa (25 mg), levodopa (100 mg), entacapone (200 mg) |
Carbidopa |
3件: D00059 D00059, D00558 D00558, D00781 D00781 💬 |
COMT 7件: COMT, DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism 17件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 1件: 6 💬 |
67 |
Carbidopa and levodopa 25mg/100mg |
Carbidopa |
2件: D00059 D00059, D00558 D00558 💬 |
DDC 6件: DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism 16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 1件: 6 💬 |
68 |
Carbidopa-levodopa 25 mg-100 mg oral tablet |
Carbidopa |
2件: D00059 D00059, D00558 D00558 💬 |
DDC 6件: DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism 16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 1件: 6 💬 |
69 |
Carbolithium*100cps 150mg |
- |
- |
- |
- |
002 1件: 2 💬 |
70 |
Cat-1004 |
- |
- |
- |
- |
113 1件: 113 💬 |
71 |
Cc-100004 |
- |
- |
- |
- |
084 1件: 84 💬 |
72 |
Cc-10004 |
- |
- |
- |
- |
046 5件: 46, 56, 97, 162, 271 💬 |
73 |
Cdp870 100mg |
- |
- |
- |
- |
046 1件: 46 💬 |
74 |
Cnto 136 100 mg |
- |
- |
- |
- |
046 1件: 46 💬 |
75 |
Cnto 6785 100 mg |
- |
- |
- |
- |
046 1件: 46 💬 |
76 |
Colimicina - 1000000 u/4 ml polvere e solvente per soluzione iniettabile per uso intramuscolare1 flaconcino polvere + 1 fiala solvente 4 ml |
- |
- |
- |
- |
299 1件: 299 💬 |
77 |
Creon 10000 |
- |
- |
- |
- |
298 2件: 298, 299 💬 |
78 |
Creon 10000 capsules |
- |
- |
- |
- |
299 1件: 299 💬 |
79 |
Cura-100 |
- |
- |
- |
- |
046 1件: 46 💬 |
80 |
Cyclophosphamide 100mg |
Cyclophosphamide |
2件: D00287 D00287, D07760 D07760 💬 |
- |
- |
060 1件: 60 💬 |
81 |
D-a-tocopheryl peg 1000 succinate |
- |
- |
- |
- |
299 1件: 299 💬 |
82 |
Defanyl 50 and 100 mg |
- |
- |
- |
- |
046 1件: 46 💬 |
83 |
Dehydroepiandrosterone 100 and 400 mg |
Prasterone |
1件: D08409 D08409 💬 |
AR 3件: AR, ESR1, ESR2 💬 |
Breast cancer 11件: Breast cancer, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Oocyte meiosis, Pathways in cancer, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Thyroid hormone signaling pathway |
113 1件: 113 💬 |
84 |
Device: ai-1000 g2 |
- |
- |
- |
- |
046 1件: 46 💬 |
85 |
Device: cellvizio 100 series system with confocal miniprobes |
- |
- |
- |
- |
215 1件: 215 💬 |
86 |
Device: centricyte 1000 |
- |
- |
- |
- |
085 2件: 85, 229 💬 |
87 |
Diagnostic test: platelet function analyzer-100 |
- |
- |
- |
- |
086 2件: 86, 88 💬 |
88 |
Doxycycline |
Doxycycline |
5件: D00307 D00307, D02129 D02129, D03903 D03903, D03904 D03904, D07876 D07876 💬 |
- |
- |
013 15件: 13, 23, 28, 46, 84, 85, 89, 96, 97, 158, 162, 167, 227, 280, 299 💬 |
89 |
Doxycycline 100 mg capsules |
Doxycycline |
5件: D00307 D00307, D02129 D02129, D03903 D03903, D03904 D03904, D07876 D07876 💬 |
- |
- |
089 1件: 89 💬 |
90 |
Doxycycline 100-200mg capsules daily for 6 months |
Doxycycline |
5件: D00307 D00307, D02129 D02129, D03903 D03903, D03904 D03904, D07876 D07876 💬 |
- |
- |
167 1件: 167 💬 |
91 |
Doxycycline hyclate |
Doxycycline |
5件: D00307 D00307, D02129 D02129, D03903 D03903, D03904 D03904, D07876 D07876 💬 |
- |
- |
023 3件: 23, 96, 227 💬 |
92 |
Doxycycline hyclate ph.eur |
Doxycycline |
5件: D00307 D00307, D02129 D02129, D03903 D03903, D03904 D03904, D07876 D07876 💬 |
- |
- |
167 1件: 167 💬 |
93 |
Doxycycline tablets |
Doxycycline |
5件: D00307 D00307, D02129 D02129, D03903 D03903, D03904 D03904, D07876 D07876 💬 |
- |
- |
046 1件: 46 💬 |
94 |
Doxyhexal® tabs 100 mg tabletten |
- |
- |
- |
- |
028 1件: 28 💬 |
95 |
Dr. reddy’s rituximab (drl_ri) 100mg |
Rituximab |
1件: D02994 D02994 💬 |
MS4A1 1件: MS4A1 💬 |
Hematopoietic cell lineage 1件: Hematopoietic cell lineage |
046 1件: 46 💬 |
96 |
Droxidopa 100 mg [northera] |
Droxidopa |
1件: D01277 D01277 💬 |
ADRA1A 9件: ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 💬 |
AMPK signaling pathway 13件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
006 1件: 6 💬 |
97 |
Epax 6000 ee 1000mg (0.6 gr dha+epa) |
- |
- |
- |
- |
046 1件: 46 💬 |
98 |
Epratuzumab 100 mg |
Epratuzumab |
1件: D04036 D04036 💬 |
CD22 1件: CD22 💬 |
B cell receptor signaling pathway 3件: B cell receptor signaling pathway, Cell adhesion molecules, Hematopoietic cell lineage |
049 1件: 49 💬 |
99 |
Eprex*1sir 10000ui 1ml |
- |
- |
- |
- |
018 1件: 18 💬 |
100 |
Epx-100 (clemizole hcl) |
Clemizole |
- |
- |
- |
140 1件: 140 💬 |
101 |
Epx-100 (clemizole hydrochloride) |
Clemizole |
- |
- |
- |
140 1件: 140 💬 |
102 |
Er tablet 100 mg azd3241 |
- |
- |
- |
- |
006 1件: 6 💬 |
103 |
Eur-1008 |
- |
- |
- |
- |
299 1件: 299 💬 |
104 |
Eur-1008 (apt-1008) |
- |
- |
- |
- |
299 1件: 299 💬 |
105 |
Eur-1008 (apt-1008) high dose |
- |
- |
- |
- |
298 1件: 298 💬 |
106 |
Eur-1008 (apt-1008) low dose |
- |
- |
- |
- |
298 1件: 298 💬 |
107 |
Eur-1008 25,000 units |
- |
- |
- |
- |
299 1件: 299 💬 |
108 |
Fanhdi 100 ui |
- |
- |
- |
- |
288 1件: 288 💬 |
109 |
Fanhdi 100 ui fviii-120 ui fvw |
- |
- |
- |
- |
288 1件: 288 💬 |
110 |
Ferriprox*100cpr riv 500mg |
- |
- |
- |
- |
120 1件: 120 💬 |
111 |
Firdapse - 10 mg - compresse - uso orale - blister(alu/pvc/pvdc) 100 x 1 compresse |
- |
- |
- |
- |
011 1件: 11 💬 |
112 |
Fostamatinib 100 mg |
Fostamatinib |
1件: D09347 D09347 💬 |
SYK 1件: SYK 💬 |
B cell receptor signaling pathway 17件: B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease - COVID-19, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis |
066 1件: 66 💬 |
113 |
Fostamatinib 100 mg tablet |
Fostamatinib |
1件: D09347 D09347 💬 |
SYK 1件: SYK 💬 |
B cell receptor signaling pathway 17件: B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease - COVID-19, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis |
066 1件: 66 💬 |
114 |
Fostamatinib disodium tablet 100 mg |
Fostamatinib |
1件: D09347 D09347 💬 |
SYK 1件: SYK 💬 |
B cell receptor signaling pathway 17件: B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease - COVID-19, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis |
066 1件: 66 💬 |
115 |
Fx-1006a |
Fx-1006A |
- |
- |
- |
028 1件: 28 💬 |
116 |
Gck 100 mg |
- |
- |
- |
- |
046 1件: 46 💬 |
117 |
Genistein (unconjugated isoflavones 100) |
Genistein |
1件: D11680 D11680 💬 |
- |
- |
299 1件: 299 💬 |
118 |
Glivec 100 mg comprimidos recubiertos con película |
- |
- |
- |
- |
034 2件: 34, 86 💬 |
119 |
Glivec 100 mg filmtabletten |
- |
- |
- |
- |
051 2件: 51, 86 💬 |
120 |
Glivec 100 mg hartkapsel |
- |
- |
- |
- |
086 1件: 86 💬 |
121 |
Glivec® 100 mg filmtabletten |
- |
- |
- |
- |
086 1件: 86 💬 |
122 |
Glpg2222 100 mg |
- |
- |
- |
- |
299 1件: 299 💬 |
123 |
Golimumab 100 mg |
Golimumab |
1件: D04358 D04358 💬 |
TNF 1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
046 2件: 46, 97 💬 |
124 |
Golimumab 100 mg injections |
Golimumab |
1件: D04358 D04358 💬 |
TNF 1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
046 1件: 46 💬 |
125 |
Golimumab 50 mg in patients <80 kg and golimumab 100 mg in patients >80 kg |
Golimumab |
1件: D04358 D04358 💬 |
TNF 1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
097 1件: 97 💬 |
126 |
Gs-9674 100 mg |
- |
- |
- |
- |
093 1件: 93 💬 |
127 |
Gsk2330811 solution for injection, 100mg/ml |
- |
- |
- |
- |
051 1件: 51 💬 |
128 |
Gsk2586184 100 mg |
- |
- |
- |
- |
049 1件: 49 💬 |
129 |
Gsk315234 injection 100mg/ml |
- |
- |
- |
- |
046 1件: 46 💬 |
130 |
Guselkumab 100 mg |
Guselkumab |
1件: D10438 D10438 💬 |
IL23A 1件: IL23A 💬 |
C-type lectin receptor signaling pathway 9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis |
037 1件: 37 💬 |
131 |
Gw-1000-02 |
- |
- |
- |
- |
013 1件: 13 💬 |
132 |
Hpn-100 |
- |
- |
- |
- |
251 1件: 251 💬 |
133 |
Ht-100 |
- |
- |
- |
- |
113 1件: 113 💬 |
134 |
Hu leptin (a-100) |
Leptin |
- |
- |
- |
265 1件: 265 💬 |
135 |
Hydrocortison 100 mg (pfizer®) in 2 ml solvent |
- |
- |
- |
- |
083 1件: 83 💬 |
136 |
Hydrocortisone 100mg/ml |
Hydrocortisone |
1件: D00088 D00088 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
083 1件: 83 💬 |
137 |
Hyqvia 100 mg/ml solution for infusion for subcutaneous use |
- |
- |
- |
- |
065 1件: 65 💬 |
138 |
Ig vena 100 ml vial |
- |
- |
- |
- |
063 1件: 63 💬 |
139 |
Ig vena 50 g/l solution for infusion 100 ml vial + infusion set |
- |
- |
- |
- |
063 2件: 63, 65 💬 |
140 |
Ilb: 100mg/ml solution for injection and infusion |
- |
- |
- |
- |
002 1件: 2 💬 |
141 |
Immediate release carbidopa/levodopa 10/100 mg |
Carbidopa |
2件: D00059 D00059, D00558 D00558 💬 |
DDC 6件: DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism 16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 1件: 6 💬 |
142 |
Immediate release carbidopa/levodopa 25/100 mg |
Carbidopa |
2件: D00059 D00059, D00558 D00558 💬 |
DDC 6件: DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism 16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 1件: 6 💬 |
143 |
Imukin*sc 6f 0,5ml 100mcg |
- |
- |
- |
- |
018 1件: 18 💬 |
144 |
Incobotulinumtoxina (100 units) |
Botulinum toxin type A |
1件: D00783 D00783 💬 |
SNAP25 1件: SNAP25 💬 |
Insulin secretion 2件: Insulin secretion, Synaptic vesicle cycle |
006 1件: 6 💬 |
145 |
Inflectra 100 mg |
- |
- |
- |
- |
097 1件: 97 💬 |
146 |
Inflectra 100 mg powder for concentrate for solution for infusion |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
147 |
Infliximab (remicade): 100 mg of lyophilized infliximab |
Infliximab |
1件: D02598 D02598 💬 |
TNF 1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
096 1件: 96 💬 |
148 |
Interferon beta 1a, oral doxycycline |
Doxycycline |
6件: D00307 D00307, D02129 D02129, D03903 D03903, D03904 D03904, D04554 D04554, D07876 D07876 💬 |
IFNAR1 2件: IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
013 1件: 13 💬 |
149 |
Intravenous (i.v.) methylprednisolone 1000 mg, total 9 |
Methylprednisolone |
6件: D00407 D00407, D00751 D00751, D00979 D00979, D05000 D05000, D05001 D05001, D05002 D05002 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
222 1件: 222 💬 |
150 |
Ipx054 100 mg |
- |
- |
- |
- |
006 1件: 6 💬 |
151 |
Isotonic sodium chloride solution |
Chloride ion |
1件: D02056 D02056 💬 |
- |
- |
034 1件: 34 💬 |
152 |
Jnj-39758979 (100 mg) |
- |
- |
- |
- |
046 1件: 46 💬 |
153 |
Jnj-39758979-aac - enteric coated tablet - 100 mg |
- |
- |
- |
- |
046 1件: 46 💬 |
154 |
Kineret*sc 7sir 100mg 0,67ml |
- |
- |
- |
- |
028 3件: 28, 46, 107 💬 |
155 |
Kiovig 100 mg/ml solution for infusion |
- |
- |
- |
- |
014 2件: 14, 65 💬 |
156 |
Kuvan 100mg soluble tablet |
- |
- |
- |
- |
240 1件: 240 💬 |
157 |
Kvd900 100 mg film coated tablet |
- |
- |
- |
- |
065 1件: 65 💬 |
158 |
Lantus 100 units/ml solution for injection in a cartridge |
- |
- |
- |
- |
299 1件: 299 💬 |
159 |
Lantus® 100 units/ml solution for injection in a vial. lantus® 100 units/ml solution for injection in a cartridge. lantus® 100 units/ml solution for injection in a pre-filled pen |
- |
- |
- |
- |
299 1件: 299 💬 |
160 |
Lcz696 100 mg |
- |
- |
- |
- |
058 1件: 58 💬 |
161 |
Levemir 100 u/ml solution for injection in a cartridge, levemir 100 u/ml solution for injection in a pre-filled pen |
- |
- |
- |
- |
299 1件: 299 💬 |
162 |
Levodopa 100 mg / benserazide 25 mg |
Benserazide |
2件: D00059 D00059, D03082 D03082 💬 |
DDC 6件: DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism 16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 1件: 6 💬 |
163 |
Levodopa 100 mg a cap |
Levodopa |
1件: D00059 D00059 💬 |
DRD1 5件: DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism 11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 1件: 6 💬 |
164 |
Levodopa 25mg/100mg |
Levodopa |
1件: D00059 D00059 💬 |
DRD1 5件: DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism 11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 1件: 6 💬 |
165 |
Levodopa/benserazide 100/25 mg |
Benserazide |
2件: D00059 D00059, D03082 D03082 💬 |
DDC 6件: DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism 16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 1件: 6 💬 |
166 |
Levodopa/carbidopa 100/25 |
Carbidopa |
2件: D00059 D00059, D00558 D00558 💬 |
DDC 6件: DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism 16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 1件: 6 💬 |
167 |
Liq861 100 µg |
- |
- |
- |
- |
086 1件: 86 💬 |
168 |
Lumacaftor/ivacaftor 100mg/125mg tablets |
Ivacaftor |
2件: D09916 D09916, D10134 D10134 💬 |
CFTR 1件: CFTR 💬 |
ABC transporters 8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway |
299 1件: 299 💬 |
169 |
Lung spheroid stem cells 100 million |
- |
- |
- |
- |
085 1件: 85 💬 |
170 |
Mabthera - 2 fiale 100 mg 10 ml |
- |
- |
- |
- |
019 2件: 19, 65 💬 |
171 |
Mabthera 100 mg concentrate for solution for infusion |
- |
- |
- |
- |
222 1件: 222 💬 |
172 |
Mabthera 100mg |
- |
- |
- |
- |
046 1件: 46 💬 |
173 |
Mabthera® 100mg |
- |
- |
- |
- |
043 1件: 43 💬 |
174 |
Mabthera®, 100 mg concentrado para solución para perfusión |
- |
- |
- |
- |
046 1件: 46 💬 |
175 |
Mabthera®, 100 mg concentrate for solution for infusion |
- |
- |
- |
- |
046 1件: 46 💬 |
176 |
Mantadan*20cpr 100mg |
- |
- |
- |
- |
013 1件: 13 💬 |
177 |
Masitinib 100 mg tablets |
Masitinib |
1件: D10229 D10229 💬 |
KIT 1件: KIT 💬 |
Acute myeloid leukemia 11件: Acute myeloid leukemia, Breast cancer, Central carbon metabolism in cancer, Hematopoietic cell lineage, MAPK signaling pathway, Melanogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway |
002 1件: 2 💬 |
178 |
Masitinib 100mg |
Masitinib |
1件: D10229 D10229 💬 |
KIT 1件: KIT 💬 |
Acute myeloid leukemia 11件: Acute myeloid leukemia, Breast cancer, Central carbon metabolism in cancer, Hematopoietic cell lineage, MAPK signaling pathway, Melanogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway |
002 2件: 2 , 5 💬 |
179 |
Mavrilimumab 100 mg |
Mavrilimumab |
1件: D09930 D09930 💬 |
CSF2RA 1件: CSF2RA 💬 |
Cytokine-cytokine receptor interaction 4件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer |
046 1件: 46 💬 |
180 |
Mbx-8025 50 mg or 100 mg (dose escalation period 2) |
MBX-8025 |
- |
- |
- |
079 1件: 79 💬 |
181 |
Mbx-8025 50 mg, 100 mg or 200 mg (dose escalation period 3) |
MBX-8025 |
- |
- |
- |
079 1件: 79 💬 |
182 |
Md1003 100 mg capsule |
- |
- |
- |
- |
020 1件: 20 💬 |
183 |
Md1003 100mg capsule |
- |
- |
- |
- |
013 1件: 13 💬 |
184 |
Medi-551 100 mg-iv |
- |
- |
- |
- |
013 1件: 13 💬 |
185 |
Mepolizumab 100 mg |
Mepolizumab |
1件: D04923 D04923 💬 |
IL5 1件: IL5 💬 |
Allograft rejection 13件: Allograft rejection, Asthma, Autoimmune thyroid disease, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, Hematopoietic cell lineage, IL-17 signaling pathway, Inflammatory bowel disease, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Pathways in cancer, T cell receptor signaling pathway, Th1 and Th2 cell differentiation |
098 1件: 98 💬 |
186 |
Mesalazine - tid 1000 mg |
Mesalazine |
1件: D00377 D00377 💬 |
- |
- |
097 1件: 97 💬 |
187 |
Mesalazine 1000 mg gastro-resistant tablets |
Mesalazine |
1件: D00377 D00377 💬 |
- |
- |
097 1件: 97 💬 |
188 |
Methotrexate*100cpr 2,5mg |
Methotrexate |
2件: D00142 D00142, D02115 D02115 💬 |
DHFR 2件: DHFR, DHFR2 💬 |
Antifolate resistance 5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
046 1件: 46 💬 |
189 |
Minocycline 100 mg film-coated tablets |
Minocycline |
2件: D00850 D00850, D05045 D05045 💬 |
- |
- |
013 1件: 13 💬 |
190 |
Minocycline 100mg |
Minocycline |
2件: D00850 D00850, D05045 D05045 💬 |
- |
- |
013 1件: 13 💬 |
191 |
Mk-8457 100 mg |
- |
- |
- |
- |
046 1件: 46 💬 |
192 |
Mycophenolate mofetil orally 1000 mg twice a day (bid) |
Mycophenolate mofetil |
4件: D00752 D00752, D05094 D05094, D05095 D05095, D05096 D05096 💬 |
IMPDH1 2件: IMPDH1, IMPDH2 💬 |
Drug metabolism - other enzymes 3件: Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism |
222 1件: 222 💬 |
193 |
Myonal*30cpr riv 100mg |
- |
- |
- |
- |
002 1件: 2 💬 |
194 |
Nacom 100 |
- |
- |
- |
- |
006 1件: 6 💬 |
195 |
Nanogam 100 mg/ml |
- |
- |
- |
- |
065 1件: 65 💬 |
196 |
Nebido® testosterone undecanoate 1000 mg/4 ml solution for injection |
Testosterone |
6件: D00075 D00075, D00957 D00957, D00958 D00958, D00959 D00959, D06085 D06085, D06087 D06087 💬 |
AR 1件: AR 💬 |
Oocyte meiosis 3件: Oocyte meiosis, Pathways in cancer, Prostate cancer |
013 1件: 13 💬 |
197 |
Neophyr 1000ppm mol/mol |
- |
- |
- |
- |
294 1件: 294 💬 |
198 |
Nerixia*infus iv conc 2f 100mg |
- |
- |
- |
- |
274 1件: 274 💬 |
199 |
Norvir 100 mg film-coated tablets |
- |
- |
- |
- |
299 1件: 299 💬 |
200 |
Novorapid 100 u/ml, solution for injection in a vial. novorapid penfill 100 u/ml, solution for injection in a cartridge. novorapid flexpen 100 u/ml, solution for injection in a pre-filled pen. |
- |
- |
- |
- |
299 1件: 299 💬 |
201 |
Noxafil 100 mg |
- |
- |
- |
- |
299 1件: 299 💬 |
202 |
Nucala 100 mg powder for solution for injection |
- |
- |
- |
- |
044 2件: 44, 45 💬 |
203 |
Octanate 100 ui/ml, poudre et solvant pour solution injectable |
Beroctocog alfa |
- |
- |
- |
288 1件: 288 💬 |
204 |
Ofatumumab 100 |
Ofatumumab |
1件: D09314 D09314 💬 |
MS4A1 1件: MS4A1 💬 |
Hematopoietic cell lineage 1件: Hematopoietic cell lineage |
013 1件: 13 💬 |
205 |
Ofev 100 mg capsule |
- |
- |
- |
- |
085 1件: 85 💬 |
206 |
Oms721 100 mg/ml injection solution, oms00620646, oms620646, masp-2 antibody |
Narsoplimab |
1件: D11531 D11531 💬 |
MASP2 1件: MASP2 💬 |
Complement and coagulation cascades 3件: Complement and coagulation cascades, Coronavirus disease - COVID-19, Staphylococcus aureus infection |
064 2件: 64, 109 💬 |
207 |
Orkambi 100 mg/125 mg film-coated tablets |
- |
- |
- |
- |
299 1件: 299 💬 |
208 |
Other: 0.9% sodium chloride |
Chloride ion |
1件: D02056 D02056 💬 |
- |
- |
065 1件: 65 💬 |
209 |
Other: 0.9ml sodium chloride |
Chloride ion |
1件: D02056 D02056 💬 |
- |
- |
271 1件: 271 💬 |
210 |
Other: 100% pomegranate juice |
Pomegranate |
- |
- |
- |
096 2件: 96, 97 💬 |
211 |
Other: no doxycycline |
Doxycycline |
5件: D00307 D00307, D02129 D02129, D03903 D03903, D03904 D03904, D07876 D07876 💬 |
- |
- |
299 1件: 299 💬 |
212 |
Other: sodium chloride |
Chloride ion |
1件: D02056 D02056 💬 |
- |
- |
051 1件: 51 💬 |
213 |
Ovastat 1000 |
Treosulfan |
1件: D07253 D07253 💬 |
- |
- |
013 2件: 13, 65 💬 |
214 |
Ovastat 1000 (treosulfan injection) |
Treosulfan |
1件: D07253 D07253 💬 |
- |
- |
065 1件: 65 💬 |
215 |
Ovastat 1000 mg, powder for solution for infusion |
Treosulfan |
1件: D07253 D07253 💬 |
- |
- |
065 1件: 65 💬 |
216 |
Part a: 100 mg/ml gsk2618960 |
- |
- |
- |
- |
013 1件: 13 💬 |
217 |
Part i- naproxen 1000 mg |
Naproxen |
1件: D00118 D00118 💬 |
PTGS1 2件: PTGS1, PTGS2 💬 |
Alzheimer disease 23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
271 1件: 271 💬 |
218 |
Part ii- naproxen 1000 mg |
Naproxen |
1件: D00118 D00118 💬 |
PTGS1 2件: PTGS1, PTGS2 💬 |
Alzheimer disease 23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
271 1件: 271 💬 |
219 |
Pentosan polysulfate sodium 100 mg |
Pentosan polysulfate |
1件: D05428 D05428 💬 |
- |
- |
226 1件: 226 💬 |
220 |
Persantin 100 mg |
- |
- |
- |
- |
046 1件: 46 💬 |
221 |
Persantin 100 mg and |
- |
- |
- |
- |
046 1件: 46 💬 |
222 |
Pf-06291826-83/fx-1006a |
Fx-1006A |
- |
- |
- |
028 1件: 28 💬 |
223 |
Pf-06480605 100 mg/ml |
- |
- |
- |
- |
097 1件: 97 💬 |
224 |
Pf-06650833 100 mg |
PF-06650833 |
- |
- |
- |
046 1件: 46 💬 |
225 |
Pf-06826647 100 mg qd |
- |
- |
- |
- |
097 1件: 97 💬 |
226 |
Physiological serum (sodium chloride) |
Chloride ion |
1件: D02056 D02056 💬 |
- |
- |
193 1件: 193 💬 |
227 |
Privigen 100 mg/ml, solution pour perfusion |
- |
- |
- |
- |
053 1件: 53 💬 |
228 |
Privigen 100mg/ml |
- |
- |
- |
- |
085 1件: 85 💬 |
229 |
Privigen® 100mg/ml at the dose of 2g/kg of body weight |
- |
- |
- |
- |
053 1件: 53 💬 |
230 |
Procedure: 9% sodium chloride (nacl) iv |
Chloride ion |
1件: D02056 D02056 💬 |
- |
- |
078 1件: 78 💬 |
231 |
Prtx-100 |
- |
- |
- |
- |
046 1件: 46 💬 |
232 |
Prtx-100 (staphylococcal protein a) |
Bevifimod |
- |
- |
- |
063 1件: 63 💬 |
233 |
Prtx-100 at 1.5 mcg/kg |
- |
- |
- |
- |
046 1件: 46 💬 |
234 |
Prtx-100 at 12.0 mcg/kg |
- |
- |
- |
- |
046 1件: 46 💬 |
235 |
Prtx-100 at 240 mcg |
- |
- |
- |
- |
046 1件: 46 💬 |
236 |
Prtx-100 at 3.0 mcg/kg |
- |
- |
- |
- |
046 1件: 46 💬 |
237 |
Prtx-100 at 420 mcg |
- |
- |
- |
- |
046 1件: 46 💬 |
238 |
Prtx-100 at 6.0 mcg/kg |
- |
- |
- |
- |
046 1件: 46 💬 |
239 |
Ptg-100 |
- |
- |
- |
- |
097 1件: 97 💬 |
240 |
Pur 0110 rectal enema 1000 mg |
- |
- |
- |
- |
097 1件: 97 💬 |
241 |
Q4w gma301 iv injections (1000 mg) |
- |
- |
- |
- |
086 1件: 86 💬 |
242 |
Radiation: diode laser 980nm&100 mwatt |
- |
- |
- |
- |
056 1件: 56 💬 |
243 |
Ranolazine 1000 mg |
Ranolazine |
2件: D05700 D05700, D05701 D05701 💬 |
- |
- |
002 1件: 2 💬 |
244 |
Ranolazine 1000 mg pr tablets |
Ranolazine |
2件: D05700 D05700, D05701 D05701 💬 |
- |
- |
058 1件: 58 💬 |
245 |
Rapamune - 1 mg 100 compresse rivestite in blister uso orale |
- |
- |
- |
- |
002 1件: 2 💬 |
246 |
Rapamune*100cpr riv 1mg |
- |
- |
- |
- |
067 1件: 67 💬 |
247 |
Raptiva 100 mg/ml powder and solvent for solution for injection |
- |
- |
- |
- |
011 7件: 11, 13, 46, 53, 61, 95, 96 💬 |
248 |
Reduced glutathione 100mg |
Glutathione |
2件: D00014 D00014, D00031 D00031 💬 |
- |
- |
006 1件: 6 💬 |
249 |
Remicade 100 mg |
- |
- |
- |
- |
056 2件: 56, 96 💬 |
250 |
Remicade 100 mg infuusiokuiva-aine, konsentraattiliuosta varten |
- |
- |
- |
- |
097 1件: 97 💬 |
251 |
Remicade 100 mg polvo para concentrado para solución para perfusión |
- |
- |
- |
- |
046 2件: 46, 271 💬 |
252 |
Remicade 100 mg powder for concentrate for solution for infusion. |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
253 |
Remicade 100 mg pulver til konsentrat til infusjonsvæske, oppløsning |
- |
- |
- |
- |
046 4件: 46, 96, 97, 271 💬 |
254 |
Remicade 100 mg pulver til konsentrat til infusjonsvæske, oppløsning. |
- |
- |
- |
- |
046 1件: 46 💬 |
255 |
Remicade*ev f 100mg+f 2ml |
- |
- |
- |
- |
046 1件: 46 💬 |
256 |
Remsima - 100 mg polvere per concentrato per soluzione per infusione - uso endovenoso - flanconcino (vetro) - 1 flaconcino |
- |
- |
- |
- |
046 4件: 46, 96, 97, 271 💬 |
257 |
Remsima 100 mg pulver til konsentrat til infusjonsvæske, oppløsning |
- |
- |
- |
- |
046 4件: 46, 96, 97, 271 💬 |
258 |
Rhudex 100 mg (127 mg rhudex choline salt) granules |
Choline |
1件: D07690 D07690 💬 |
- |
- |
093 1件: 93 💬 |
259 |
Riluzole (100 mg) |
Riluzole |
1件: D00775 D00775 💬 |
GRIA1 14件: GRIA1, GRIA2, GRIA3, GRIA4, GRIK1, GRIK2, GRIK3, GRIK4, GRIK5, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 |
Alcoholism 23件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Systemic lupus erythematosus, Transcriptional misregulation in cancer, cAMP signaling pathway |
002 1件: 2 💬 |
260 |
Rwj-445380 100 mg |
- |
- |
- |
- |
046 1件: 46 💬 |
261 |
Rwj-445380 capsule 100 mg |
- |
- |
- |
- |
046 1件: 46 💬 |
262 |
Safinamide methanesulfonate 100mg |
Safinamide |
1件: D10158 D10158 💬 |
MAOB 1件: MAOB 💬 |
Alcoholism 14件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism |
006 1件: 6 💬 |
263 |
Safinimide 50-100 mg/day |
- |
- |
- |
- |
006 1件: 6 💬 |
264 |
Salofalk 1000mg granu-stix |
- |
- |
- |
- |
097 1件: 97 💬 |
265 |
Salofalk 1000mg granu-stix® |
- |
- |
- |
- |
097 1件: 97 💬 |
266 |
Salofalk® 1000mg granu-stix® |
- |
- |
- |
- |
097 1件: 97 💬 |
267 |
Sandimmun neoral*30cps 100mg |
- |
- |
- |
- |
046 1件: 46 💬 |
268 |
Sch 420814 100 mg |
- |
- |
- |
- |
006 1件: 6 💬 |
269 |
Sinemet 10-100 |
- |
- |
- |
- |
006 1件: 6 💬 |
270 |
Sinemet 100 mg + 25 mg compresse |
- |
- |
- |
- |
006 1件: 6 💬 |
271 |
Sinemet 25-100 |
- |
- |
- |
- |
006 1件: 6 💬 |
272 |
Sinemet 25/100 |
- |
- |
- |
- |
006 1件: 6 💬 |
273 |
Sinemet cr 25mg-100mg extended-release tablet |
- |
- |
- |
- |
006 1件: 6 💬 |
274 |
Sinemet*50cpr 100mg+25mg |
- |
- |
- |
- |
006 1件: 6 💬 |
275 |
Sinemet® 100/25 |
- |
- |
- |
- |
006 1件: 6 💬 |
276 |
Sinemet® 100/25 mg |
- |
- |
- |
- |
006 1件: 6 💬 |
277 |
Sinemet® cr 100/25 |
- |
- |
- |
- |
006 1件: 6 💬 |
278 |
Sinemet® plus 25 mg/100 mg tablets |
- |
- |
- |
- |
006 1件: 6 💬 |
279 |
Sinemet®25-100 |
- |
- |
- |
- |
006 1件: 6 💬 |
280 |
Sirio*30cpr eff 25mg+100mg |
- |
- |
- |
- |
006 1件: 6 💬 |
281 |
Sirukumab 100 mg |
Sirukumab |
1件: D10080 D10080 💬 |
IL6 1件: IL6 💬 |
AGE-RAGE signaling pathway in diabetic complications 49件: AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Alzheimer disease, Amoebiasis, Antifolate resistance, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Malaria, Measles, NOD-like receptor signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Salmonella infection, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Tuberculosis, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection |
046 1件: 46 💬 |
282 |
Sodium chloride |
Chloride ion |
1件: D02056 D02056 💬 |
- |
- |
006 20件: 6 , 11, 13, 14, 34, 46, 50, 51, 53, 60, 65, 78, 96, 168, 193, 227, 228, 271, 288, 299 💬 |
283 |
Sodium chloride (7%) |
Chloride ion |
1件: D02056 D02056 💬 |
- |
- |
299 1件: 299 💬 |
284 |
Sodium chloride 0,9% |
Chloride ion |
1件: D02056 D02056 💬 |
- |
- |
299 1件: 299 💬 |
285 |
Sodium chloride 0.9% |
Chloride ion |
1件: D02056 D02056 💬 |
- |
- |
014 1件: 14 💬 |
286 |
Sodium chloride 6% |
Chloride ion |
1件: D02056 D02056 💬 |
- |
- |
299 1件: 299 💬 |
287 |
Sodium chloride 7% |
Chloride ion |
1件: D02056 D02056 💬 |
- |
- |
299 1件: 299 💬 |
288 |
Sodium chloride ph. eur. |
Chloride ion |
1件: D02056 D02056 💬 |
- |
- |
299 1件: 299 💬 |
289 |
Sodium chloride solution |
Chloride ion |
1件: D02056 D02056 💬 |
- |
- |
011 3件: 11, 13, 228 💬 |
290 |
Sodium chloride solution 0.9% |
Chloride ion |
1件: D02056 D02056 💬 |
- |
- |
060 3件: 60, 288, 299 💬 |
291 |
Sodium chloride solvent |
Chloride ion |
1件: D02056 D02056 💬 |
- |
- |
228 1件: 228 💬 |
292 |
Sodium pyruvate in 0.9% sodium chloride solution |
Chloride ion |
1件: D02056 D02056 💬 |
- |
- |
299 1件: 299 💬 |
293 |
Solu-cortef, powder for solution for injection, 100mg, and 'act-o-vial' |
- |
- |
- |
- |
006 1件: 6 💬 |
294 |
Solucion de cloruro de sodio sodium chloride solution |
Chloride ion |
1件: D02056 D02056 💬 |
- |
- |
228 1件: 228 💬 |
295 |
Solvente cloruro de sodio sodium chloride solvent |
Chloride ion |
1件: D02056 D02056 💬 |
- |
- |
228 1件: 228 💬 |
296 |
Som3355 100mg bid |
- |
- |
- |
- |
008 1件: 8 💬 |
297 |
Spi-1005 ebselen 200mg capsule x1 |
Ebselen |
- |
- |
- |
299 1件: 299 💬 |
298 |
Spi-1005 ebselen 200mg capsule x2 |
Ebselen |
- |
- |
- |
299 1件: 299 💬 |
299 |
Spi-1005 ebselen 200mg capsule x3 |
Ebselen |
- |
- |
- |
299 1件: 299 💬 |
300 |
Ssp-004184 100 mg |
- |
- |
- |
- |
284 1件: 284 💬 |
301 |
Ssp-004184 100 mg capsule |
- |
- |
- |
- |
284 1件: 284 💬 |
302 |
Ssp-004184aq 100 mg |
- |
- |
- |
- |
284 1件: 284 💬 |
303 |
Ssp-004184aq 100 mg capsule |
- |
- |
- |
- |
284 1件: 284 💬 |
304 |
Stalevo 100 |
- |
- |
- |
- |
006 1件: 6 💬 |
305 |
Stalevo 100 mg/ 25 mg/ 200 mg filmtabletten |
- |
- |
- |
- |
006 1件: 6 💬 |
306 |
Stalevo 100 mg/25 mg / 200 mg |
- |
- |
- |
- |
006 1件: 6 💬 |
307 |
Stalevo 100/25/200 mg |
- |
- |
- |
- |
006 1件: 6 💬 |
308 |
Stalevo*100cpr 100/25/200mg |
- |
- |
- |
- |
006 1件: 6 💬 |
309 |
Stalevo*100cpr 50/12,5/200mg |
- |
- |
- |
- |
006 1件: 6 💬 |
310 |
Symkevi 100mg/150mg film-coated tablets |
- |
- |
- |
- |
299 1件: 299 💬 |
311 |
T 100 pari |
- |
- |
- |
- |
299 1件: 299 💬 |
312 |
Tachipirina - 1000 mg compresse 8 compresse |
- |
- |
- |
- |
014 1件: 14 💬 |
313 |
Tezacaftor/ivacaftor 100mg/150mg |
Ivacaftor |
2件: D09916 D09916, D11041 D11041 💬 |
CFTR 1件: CFTR 💬 |
ABC transporters 8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway |
299 1件: 299 💬 |
314 |
Tezacaftor/ivacaftor/100mg/150mg |
Ivacaftor |
2件: D09916 D09916, D11041 D11041 💬 |
CFTR 1件: CFTR 💬 |
ABC transporters 8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway |
299 1件: 299 💬 |
315 |
Thalidomide 100mg |
Thalidomide |
1件: D00754 D00754 💬 |
TNF 1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
271 1件: 271 💬 |
316 |
Tildrakizumab 100 mg (one 1-ml injection of 100 mg/ml |
Tildrakizumab |
1件: D10400 D10400 💬 |
IL23A 1件: IL23A 💬 |
C-type lectin receptor signaling pathway 9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis |
271 1件: 271 💬 |
317 |
Tildrakizumab 100 mg/ml |
Tildrakizumab |
1件: D10400 D10400 💬 |
IL23A 1件: IL23A 💬 |
C-type lectin receptor signaling pathway 9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis |
271 1件: 271 💬 |
318 |
Tildrakizumab 200 mg (two 1-ml injections of 100 mg/ml) |
Tildrakizumab |
1件: D10400 D10400 💬 |
IL23A 1件: IL23A 💬 |
C-type lectin receptor signaling pathway 9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis |
271 1件: 271 💬 |
319 |
Tobramycin 100 pari |
Tobramycin |
2件: D00063 D00063, D02542 D02542 💬 |
- |
- |
299 1件: 299 💬 |
320 |
Tranexamic acid 100 mg/ml |
Tranexamic acid |
1件: D01136 D01136 💬 |
PLG 1件: PLG 💬 |
Complement and coagulation cascades 4件: Complement and coagulation cascades, Influenza A, Neuroactive ligand-receptor interaction, Staphylococcus aureus infection |
070 1件: 70 💬 |
321 |
Translarna 1000 mg granules for oral suspension |
- |
- |
- |
- |
113 1件: 113 💬 |
322 |
Treatment with systemic therapy (doxycycline) |
Doxycycline |
5件: D00307 D00307, D02129 D02129, D03903 D03903, D03904 D03904, D07876 D07876 💬 |
- |
- |
162 1件: 162 💬 |
323 |
Trk-100stp |
- |
- |
- |
- |
086 1件: 86 💬 |
324 |
Tu-100 |
TU-100 |
- |
- |
- |
096 1件: 96 💬 |
325 |
Unconjugated isoflavones 100 (pti g-4660, 87% genistein) |
Genistein |
1件: D11680 D11680 💬 |
- |
- |
299 1件: 299 💬 |
326 |
Urbason solubile forte 1000mg |
- |
- |
- |
- |
013 1件: 13 💬 |
327 |
Urbason® solubile forte 1000 mg |
- |
- |
- |
- |
013 1件: 13 💬 |
328 |
Uvedose 100 000 ui |
- |
- |
- |
- |
013 1件: 13 💬 |
329 |
Uvedose 100 000 ui, solution buvable en ampoule |
- |
- |
- |
- |
013 1件: 13 💬 |
330 |
Vibrox 100mg capsules |
- |
- |
- |
- |
167 1件: 167 💬 |
331 |
Vitamin d 100ug |
Vitamin D |
- |
- |
- |
298 1件: 298 💬 |
332 |
Vsn16r 100mg |
- |
- |
- |
- |
013 1件: 13 💬 |
333 |
Vx-661/ivacaftor (vx-770) 100mg/150 mg |
Ivacaftor |
1件: D09916 D09916 💬 |
CFTR 1件: CFTR 💬 |
ABC transporters 8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway |
299 1件: 299 💬 |
334 |
Vx-661/ivacaftor 100 mg/ 150 mg |
Ivacaftor |
1件: D09916 D09916 💬 |
CFTR 1件: CFTR 💬 |
ABC transporters 8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway |
299 1件: 299 💬 |
335 |
Vx-661/ivacaftor 100mg/150 mg |
Ivacaftor |
1件: D09916 D09916 💬 |
CFTR 1件: CFTR 💬 |
ABC transporters 8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway |
299 1件: 299 💬 |
336 |
Vx-661/ivacaftor 100mg/150mg |
Ivacaftor |
1件: D09916 D09916 💬 |
CFTR 1件: CFTR 💬 |
ABC transporters 8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway |
299 1件: 299 💬 |
337 |
Wilate 1000 |
- |
- |
- |
- |
288 1件: 288 💬 |
338 |
Wilate 1000 i.u. |
- |
- |
- |
- |
288 1件: 288 💬 |
339 |
Win-1001x |
- |
- |
- |
- |
006 1件: 6 💬 |
340 |
Zavesca 84cps 100mg |
- |
- |
- |
- |
019 1件: 19 💬 |
341 |
Zoledronic acid 5mg/bag 100ml inj |
Zoledronic acid |
4件: D01968 D01968, D06378 D06378, D06379 D06379, D08689 D08689 💬 |
FDPS 1件: FDPS 💬 |
Human T-cell leukemia virus 1 infection 4件: Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis |
006 1件: 6 💬 |
342 |
Zoledronic acid kern pharma 4 mg/100 ml solution for infusion, generic medicinal product |
Zoledronic acid |
4件: D01968 D01968, D06378 D06378, D06379 D06379, D08689 D08689 💬 |
FDPS 1件: FDPS 💬 |
Human T-cell leukemia virus 1 infection 4件: Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis |
274 1件: 274 💬 |
343 |
Zoledronic acid kern pharma 4 mg/100 ml solution for infusion, generic medicinal product. |
Zoledronic acid |
4件: D01968 D01968, D06378 D06378, D06379 D06379, D08689 D08689 💬 |
FDPS 1件: FDPS 💬 |
Human T-cell leukemia virus 1 infection 4件: Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis |
274 1件: 274 💬 |
344 |
Zoledronic acid kern pharma 4 mg/100 ml solution for infusion,generic medicinal product |
Zoledronic acid |
4件: D01968 D01968, D06378 D06378, D06379 D06379, D08689 D08689 💬 |
FDPS 1件: FDPS 💬 |
Human T-cell leukemia virus 1 infection 4件: Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis |
274 1件: 274 💬 |